Valuation: Integra LifeSciences Holdings Corporation

Market Cap 140.42Cr 122.76Cr 112.81Cr 105.16Cr 199.45Cr 13TCr 202.48Cr 1.35TCr 526.5Cr 6.57TCr 527.09Cr 515.78Cr 23TCr P/E 2026 *
27.8x
P/E 2027 * 15x
Enterprise Value 274.26Cr 239.76Cr 220.34Cr 205.38Cr 389.54Cr 26TCr 395.45Cr 2.65TCr 1.03TCr 13TCr 1.03TCr 1.01TCr 44TCr EV / Sales 2026 *
1.64x
EV / Sales 2027 * 1.49x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+0.89%
1 week-3.78%
Current month+0.50%
1 month+2.79%
3 months+89.40%
6 months+50.29%
Current year+45.33%
1 week 17.76
Extreme 17.76
18.92
1 month 16.75
Extreme 16.75
18.92
Current year 8.7
Extreme 8.7
18.92
1 year 8.7
Extreme 8.7
18.92
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
01/06Free

Chief Executive Officer

10,70,765 1.3758%
01/06Free

Executive/Senior Manager

92,281 0.1186%
09/05Tax

Director

-882 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%-3.78%+33.80%-55.98% 140.42Cr
+3.49%+1.36%-29.04%-11.02% 17TCr
+5.04%+2.73%-5.88%-4.53% 11TCr
+2.80%+3.63%+0.09%+55.31% 5.77TCr
+1.33%+1.39%+55.88%+50.01% 5.38TCr
+3.39%+1.39%-10.26%-39.65% 4.36TCr
+3.50%+11.11% - - 3.65TCr
+3.47%+1.58%-14.08%-43.91% 2.75TCr
+0.20%+4.24%+64.56%-3.33% 2.58TCr
+2.78%+1.17%-8.15%-0.43% 2.13TCr
Average +2.69%+4.18%+9.66%-5.95% 5.4TCr
Weighted average by Cap. +3.31%+3.79%-3.44%+0.91%

Financials

2026 *2027 *
Net sales 167.58Cr 146.49Cr 134.63Cr 125.49Cr 238.02Cr 16TCr 241.63Cr 1.62TCr 628.31Cr 7.84TCr 629.01Cr 615.51Cr 27TCr 173.17Cr 151.38Cr 139.12Cr 129.68Cr 245.96Cr 16TCr 249.69Cr 1.67TCr 649.27Cr 8.1TCr 650Cr 636.04Cr 28TCr
Net income 4.27Cr 3.74Cr 3.43Cr 3.2Cr 6.07Cr 406.87Cr 6.16Cr 41Cr 16Cr 200Cr 16Cr 16Cr 689.18Cr 7.46Cr 6.52Cr 5.99Cr 5.58Cr 11Cr 709.96Cr 11Cr 72Cr 28Cr 348.98Cr 28Cr 27Cr 1.2TCr
Net Debt 133.83Cr 117Cr 107.52Cr 100.22Cr 190.09Cr 13TCr 192.97Cr 1.29TCr 501.8Cr 6.26TCr 502.36Cr 491.57Cr 22TCr 117.59Cr 102.8Cr 94Cr 88Cr 167.02Cr 11TCr 169.56Cr 1.13TCr 440.9Cr 5.5TCr 441.4Cr 431.92Cr 19TCr
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
02/26/02 $18.05 +0.89% 6,83,034
01/26/01 $17.89 -0.39% 8,04,611
30/26/30 $17.96 -4.16% 9,35,976
29/26/29 $18.74 -0.11% 9,87,834
26/26/26 $18.76 +3.65% 21,57,462
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
18.05USD
Average target price
17.43USD
Spread / Average Target
-3.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock